Replies to post #18455 on MannKind Corp. (MNKD)

[bakersson]

They might in a years time.

[Hypi]

I agree a lawsuit against a BP is like pissing into the wind. Let's move on and execute, while making SNY regret their lackluster effort in marketing Afrezza.

[Phaeton]

There will be arbitration and no lawsuit. MannKind Will prevail because it's clearly evident that sanofi did not really deal with their partner. But everybody can see what kind of problems sanofi currently has in their diabetes offering. The FDA is currently questioning whether or not their new product lixilin even serves a purpose. They lost a lawsuit in federal court on their marquee product Praulant which was there cholesterol reducing diabetes offering through Regeneron. This will cost them perhaps $1 billion or more. And they will have to hold the drug. Amgen is happy about that. There Lantus replacement this struggling too. Toujeo is not selling well. So they fired the VP of diabetes Pascale Witz. So perhaps MannKind is in a better place to be away from their French partner.